Working… Menu

A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02269735
Recruitment Status : Completed
First Posted : October 21, 2014
Last Update Posted : January 15, 2019
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.